Tandem reactions are an effective tool in modern organic synthesis that has been successfully used to construct a variety of acyclic, carbo-and heterocyclic systems [2] [3] [4] [5] [6] . In the field of heterocyclic compound chemistry, for instance, tandem condensation of alkyl 2-azidobenzoates with activated acetonitriles is a basis for efficient synthesis of [1,2,3]triazolo[1,5-a]quinazoline derivatives [7] [8] [9] , such as the known selective serotonin 5-HT 6 receptor antagonists [7] and inhibitors of the biosynthesis of teichoic acid, a component of the cell wall of many gram-positive bacteria [9] . Among the azidobenzoate pyrazole analogs such transformations are described only for ethyl 5-azido-1-methyl-4-pyrazolecarboxylate, reaction of which with activated nitriles gave 3-substituted pyrazolo [4,3-e][1,2,3]triazolo[1,5-a]pyrimidines [10] . To us it seemed worthwhile to exploit the synthetic potential of tandem reactions of other pyrazole functional derivatives with cyanoacetic acid amides to obtain new condensed heterocyclic compounds.
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In this work, 4-(azidomethyl)pyrazole-3-carboxylic acid esters 2a-c, formed in essentially quantitative yields by reacting 4-chloromethylpyrazole-3-carboxylic acid ethyl ester 1a-c [11] with sodium azide in DMF solution at 50°C, were studied as potential substrates for tandem condensation reactions. A characteristic of compounds 2a-c is the location of the azide group in the γ-position relative to the ester group, which is an important prerequisite for the formation of a seven-membered heterocyclic system. Of the compounds with this placement of substituents, only 2-azidobenzylacetate have been previously used in cyclocondensation with cyanoacetamide [12] .
We have found that 4-(azidomethyl)pyrazole-3-carboxylic acid esters 2a-c react with cyanoacetamides 3a-e in refluxing THF in the presence of t-BuOK, forming pyrazolo [3,4-e] [1, 2, 3] triazolo[1,5-a]diazepine-3-carboxamides 4a-g in 53-67% yields. This transformation is presumably an example of a tandem reaction that begins with the cycloaddition to the azido group of a carbanion, generated from cyanoacetamide, and the formation of an intermediate polyfunctional triazole A, susceptible to the formation of the diazepine cycle due to the intramolecular attack of the triazole amino group on the ethoxycarbonyl group of the pyrazole ring. Compounds 4a-g are the first representatives of a previously unknown heterocyclic system, which holds promise as a scaffold for the design of bioactive substances owing to the presence of endo-and exocyclic amide fragments in its structure. The structure of target compounds was confirmed by various analytical methods (Tables 1-4 ). It should be noted that the absence of signals in the downfield region (160-190 ppm) of the 13 C NMR spectra excludes the possibility for the formation of the alternative Claisen condensation/cycloaddition tandem reaction products, 9-oxo-5,7,9,10-tetrahydropyrazolo [3,4-e] tetrazolo[1,5-a]azepine-10-carboxamides. Employing the APT method for the analysis of 13 C NMR spectra and comparison with published data [8, 13] allowed for a comparatively accurate assignment of signals to the corresponding carbon atoms in the triazolodiazepine cycle: C-3 (127-128 ppm), C-3a (137-139), C-5 (157-159), C-5a (141-143), C-8a (116-118), C-9 (42-43 ppm).
Thus, in this study the efficiency of using the condensation of 4-(azidomethyl)pyrazole-3-carboxylic acid ethyl ester with cyanoacetamides for one-pot synthesis of derivatives of a previously unknown pyrazolo [3,4- С NMR spectra were recorded on a Bruker Avance DRX-500 spectrometer (500 and 125 MHz, respectively) in DMSO-d 6 with TMS as internal standard. Mass spectra were acquired on an Agilent LC/MSD SL mass spectrometer; Zorbax SB-C18 
4-Azidomethyl-1-methyl(aryl)-1Н-pyrazole-3-carboxylic Acid Ethyl Esters 2а-с (General Method).
NaN 3 (1.62 g 0.025 mol) was added to a solution of 4-chloromethylpyrazole 1а-с (0.01 mol) in DMF (20 ml). The mixture was stirred at 50°С for 3 h. The reaction mixture was cooled and poured into ice water (100 ml). The formed precipitate (compounds 2b,c) was filtered off, washed with ice water (2×20 ml), dried in air, and recrystallized from ethanol. Alternatively, the oily layer (compound 2а) was extracted with CH 2 Cl 2 (2×30 ml), dried over anhydrous Na 2 SO 4 , and the solvent was removed. An analytically pure oily substance was obtained.
1 [14, 15] (0.002 mol) and t-BuOK (0.25 g, 0.0022 mol) were successively added to a solution of azidomethylcarboxylate 2а-с (0.002 mol) in THF (15 ml). The mixture was heated under reflux for 5 h. The solvent was removed by distillation. The residue was dissolved in water (30 ml) and acidified with 10% HСl to рН 3. The formed precipitate was filtered off, washed with water (2×10 ml), dried, and recrystallized from PhMe.
